☰

Aniruddha C. Amrite, Ph.D. - Publications

Affiliations: 
2007 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Ophthalmology, Pharmacology
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Progress in Retinal and Eye Research. 36: 172-98. PMID 23603534 DOI: 10.1016/J.Preteyeres.2013.04.001  0.579
2010 Missel P, Chastain J, Mitra A, Kompella U, Kansara V, Duvvuri S, Amrite A, Cheruvu N. In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 26: 137-46. PMID 20415622 DOI: 10.1089/Jop.2009.0132  0.521
2010 Amrite A, Pugazhenthi V, Cheruvu N, Kompella U. Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes. Expert Opinion On Drug Delivery. 7: 631-45. PMID 20205602 DOI: 10.1517/17425241003663236  0.645
2009 Cheruvu NP, Amrite AC, Kompella UB. Effect of diabetes on transscleral delivery of celecoxib. Pharmaceutical Research. 26: 404-14. PMID 18987961 DOI: 10.1007/S11095-008-9757-2  0.597
2008 Amrite AC, Edelhauser HF, Singh SR, Kompella UB. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Molecular Vision. 14: 150-60. PMID 18334929  0.611
2008 Cheruvu NP, Amrite AC, Kompella UB. Effect of eye pigmentation on transscleral drug delivery. Investigative Ophthalmology & Visual Science. 49: 333-41. PMID 18172110 DOI: 10.1167/Iovs.07-0214  0.563
2008 Amrite AC, Edelhauser HF, Kompella UB. Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Investigative Ophthalmology & Visual Science. 49: 320-32. PMID 18172109 DOI: 10.1167/Iovs.07-0593  0.569
2008 Amrite AC, Kompella UB. Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism. The Journal of Pharmacology and Experimental Therapeutics. 324: 749-58. PMID 18032574 DOI: 10.1124/Jpet.107.128918  0.601
2006 Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Investigative Ophthalmology & Visual Science. 47: 1149-60. PMID 16505053 DOI: 10.1167/Iovs.05-0531  0.688
2005 Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. The Journal of Pharmacy and Pharmacology. 57: 1555-63. PMID 16354399 DOI: 10.1211/Jpp.57.12.0005  0.524
2004 Ayalasomayajula SP, Amrite AC, Kompella UB. Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. European Journal of Pharmacology. 498: 275-8. PMID 15364005 DOI: 10.1016/J.Ejphar.2004.07.046  0.674
2004 Amrite AC, Cheruvu NPS, Sundaram S, Aravalli RN, Cheng PW, Kompella UB. Lung gene therapy: Clinical and regulatory issues Clinical Research and Regulatory Affairs. 21: 1-28. DOI: 10.1081/Crp-120039559  0.573
Show low-probability matches.